Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.
- 6 June 1995
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 92 (12) , 5287-5291
- https://doi.org/10.1073/pnas.92.12.5287
Abstract
BCR-ABL is a chimeric oncogene generated by translocation of sequences from the c-abl protein-tyrosine kinase gene on chromosome 9 into the BCR gene on chromosome 22. Alternative chimeric proteins, p210BCR-ABL and p190BCR-ABL, are produced that are characteristic of chronic myelogenous leukemia and acute lymphoblastic leukemia, respectively. Their role in the etiology of human leukemia remains to be defined. Transformed murine hematopoietic cells can be used as a model of BCR-ABL function since these cells can be made growth factor independent and tumorigenic by the action of the BCR-ABL oncogene. We show that the BCR-ABL oncogenes prevent apoptotic death in these cells by inducing a Bcl-2 expression pathway. Furthermore, BCR-ABL-expressing cells revert to factor dependence and nontumorigenicity after Bcl-2 expression is suppressed. These results help to explain the ability of BCR-ABL oncogenes to synergize with c-myc in cell transformation.Keywords
This publication has 38 references indexed in Scilit:
- In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequenceNature, 1994
- Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cellsNature, 1988
- Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemiaCell, 1987
- Role of myc in the abrogation of IL3 dependence of myeloid FDC-P1 cells.1987
- The CML-Specific P210 bcr / abl Protein, Unlike v- abl , Does Not Transform NIH/3T3 FibroblastsScience, 1987
- Unique Forms of the abl Tyrosine Kinase Distinguish Ph 1 -Positive CML from Ph 1 -Positive ALLScience, 1987
- IL3-dependent mouse clones that express B-220 surface antigen, contain ig genes in germ-line configuration, and generate B lymphocytes in vivoCell, 1985
- Fused transcript of abl and bcr genes in chronic myelogenous leukaemiaNature, 1985
- An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activityCell, 1984
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.1975